What is Needleless Syringe?
The needle-free injection system is a new way to introduce several medicines into patients without piercing the skin. The technology offers numerous benefits by reducing the patient concern about the use of the needle. Moreover, needle-free injection gives very effective injections for a wide range of bioequivalent and drugs to syringe and needle, results in less pain, and is strongly preferred by patients. Nowadays, companies are steadily developing technology that promises to make the administration of medicine more efficient and less painful.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Portal Instruments (United States), 3M (United States), Becton Dickinson (United States), B. Braun Medical (Germany), Medline Industries, Inc. (United States), Antares Pharma, Inc. (United States), Injex Pharma AG (Germany), PharmaJet (United States), Zogenix, Inc. (United States) and BioJect Medical Technologies (United States) |
The study covers a detailed analysis segmented by key business segments i.e. by type (Jet Injectors, Inhaler Technology, Transdermal Patch and Novel Needle Free Technologies) , by application (Vaccine Delivery, Pain Management, Insulin Delivery For Diabetes and Pediatric Injections) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Needleless Syringe market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Needleless Syringe market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Portal Instruments (United States), 3M (United States), Becton Dickinson (United States), B. Braun Medical (Germany), Medline Industries, Inc. (United States), Antares Pharma, Inc. (United States), Injex Pharma AG (Germany), PharmaJet (United States), Zogenix, Inc. (United States) and BioJect Medical Technologies (United States).
Restraints
- A High Cost of the Needleless Syringes
Opportunities
The Developing Healthcare Infrastructure among the Developing Countries
Key highlights of the Global Needleless Syringe market Study:
CAGR of the market during the forecast period 2021-2027
In-depth information on growth factors that will accelerate the Needleless Syringe market in next few years.
Detailed Insights on futuristic trends and changing consumer behaviour
Forecast of the Global Needleless Syringe market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Needleless Syringe Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Needleless Syringe market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Needleless Syringe market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Needless Syringe Manufacturers, Raw Material Suppliers, Needless Syringe Traders/Distributors, Needless Syringe Importer/Exporter, Regulatory & Government Bodies, End Users and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.